Nippon India Nifty Pharma Etf Datagrid
Category Other ETFs
BMSMONEY Rank 5
Rating
Growth Option
NAV (R) % (D) %
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular
Direct
Benchmark
SIP (XIRR) Regular
Direct
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
1.01 0.53 0.94 -% -
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
16.68% -18.91% -15.21% - 11.96%
Fund AUM As on: 30/12/2025 1019 Cr

No data available

NAV Date:

no data

Review Date:


Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

Data Source: www.amfiindia.com

SEBI Categorization


KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
Standard Deviation 16.68
19.14
0.00 | 68.78 64 | 135 Good
Semi Deviation 11.96
14.24
0.00 | 56.74 57 | 135 Good
Max Drawdown % -15.21
-22.46
-93.23 | 0.00 36 | 135 Good
VaR 1 Y % -18.91
-23.97
-50.15 | 0.00 28 | 135 Very Good
Average Drawdown % 6.41
9.36
0.00 | 48.21 93 | 135 Average
Sharpe Ratio 1.01
-1.19
-119.91 | 1.41 7 | 133 Very Good
Sterling Ratio 0.94
0.45
-0.49 | 1.49 14 | 135 Very Good
Sortino Ratio 0.53
0.19
-1.00 | 0.86 15 | 135 Very Good
Return data last Updated On :
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
Standard Deviation 16.68 19.14 0.00 | 68.78 64 | 135 Good
Semi Deviation 11.96 14.24 0.00 | 56.74 57 | 135 Good
Max Drawdown % -15.21 -22.46 -93.23 | 0.00 36 | 135 Good
VaR 1 Y % -18.91 -23.97 -50.15 | 0.00 28 | 135 Very Good
Average Drawdown % 6.41 9.36 0.00 | 48.21 93 | 135 Average
Sharpe Ratio 1.01 -1.19 -119.91 | 1.41 7 | 133 Very Good
Sterling Ratio 0.94 0.45 -0.49 | 1.49 14 | 135 Very Good
Sortino Ratio 0.53 0.19 -1.00 | 0.86 15 | 135 Very Good
Return data last Updated On :
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


Date Nippon India Nifty Pharma Etf NAV Regular Growth Nippon India Nifty Pharma Etf NAV Direct Growth
18-08-2026 27.1122 None
17-08-2026 27.0914 None
14-08-2026 27.1987 None
13-08-2026 27.4466 None
12-08-2026 27.5245 None
11-08-2026 27.5123 None
10-08-2026 27.2299 None
07-08-2026 27.2943 None
06-08-2026 27.3141 None
05-08-2026 27.313 None
04-08-2026 27.3443 None
03-08-2026 27.4114 None
31-07-2026 27.2805 None
30-07-2026 27.0871 None
29-07-2026 27.1152 None
28-07-2026 26.7311 None
27-07-2026 26.6768 None
24-07-2026 26.2696 None
23-07-2026 26.3666 None
22-07-2026 26.468 None
21-07-2026 26.8175 None
20-07-2026 26.7257 None

Fund Launch Date: 02/Jul/2021
Fund Category: Other ETFs
Investment Objective: The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the Nifty Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.
Fund Description: An open ended scheme replicating/ tracking NIFTY Pharma Index
Fund Benchmark: Nifty Pharma Total Return Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.